Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001104659-25-101914
Filing Date
2025-10-24
Accepted
2025-10-23 20:27:51
Documents
1
Effectiveness Date
2025-10-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9276
  Complete submission text file 0001104659-25-101914.txt   10829
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-561937 | Film No.: 251414081
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)